A Novel Genetically Modified Adenovirus Vector Shows Enhanced Infectivity towards Ex Vivo Pancreatic Cancer

被引：0
|
作者：
van Geer, Michael [1 ]
Bosma, Piter [1 ]
Kuhlmann, Koert [2 ]
Bakker, Conny [1 ]
Gouma, Dirk [2 ]
Elferink, Ronald Oude [1 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, AMC Liver Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.864
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
778
引用
收藏
页码：S301 / S301
页数：1
相关论文
共 48 条
  • [1] A fiber modified adenovirus vector that targets to the EphrinA2 receptor reveals enhanced gene transfer to ex vivo pancreatic cancer
    Van Geer, Michael A.
    Brevoord, Daniel
    Kuhlmann, Koert F. D.
    Bakker, Conny T.
    Mizuguchi, Hiroyuki
    Wesseling, John G.
    Ten Kate, Fibo J.
    Gouma, Dirk J.
    Elferink, Ronald P. J. Oude
    Bosma, Piter J.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 36 (01) : 233 - 244
  • [2] Intravenous administration of infectivity enhanced conditionally replicative adenovirus shows augmented antitumor effect in orthotopic pancreatic cancer model
    Ramirez, PJ
    Davydova, J
    Curiel, DT
    Vickers, SM
    Yamamoto, M
    GASTROENTEROLOGY, 2005, 128 (04) : A109 - A109
  • [3] Genetically enhanced DC vaccines for cancer: Bringing the ex vivo, in vivo
    Kemnade, Jan Ole
    Collinson-Pautz, Matthew
    Narayanan, Priyadharshini
    Lapteva, Natalia
    Seethammagari, Mamatha
    Spence, David
    CANCER RESEARCH, 2011, 71
  • [4] A novel molecular approach to ex vivo expansion of hematopoietic progenitors using an adenovirus vector
    Takahashi, T
    Tanaka, T
    Kumano, K
    Kurokawa, M
    Hirano, N
    Sasaki, K
    Honda, H
    Chiba, S
    Saito, I
    Shibata, Y
    Nakahata, T
    Yazaki, Y
    Hirai, H
    BLOOD, 1996, 88 (10) : 3930 - 3930
  • [5] Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer
    Yamamoto, M
    Davydova, J
    Wang, MH
    Siegal, GP
    Krasnykh, V
    Vickers, SM
    Curiel, DT
    GASTROENTEROLOGY, 2003, 125 (04) : 1203 - 1218
  • [6] Anti TGF-β Pancreatic Cancer Gene Therapy with Infectivity Enhanced Adenovirus Expressing Soluble TGF-β Receptor II
    Hoshino, Shigenori
    Adachi, Yasuo
    Brown, Eric
    Vickers, Selwyn M.
    Yamamoto, Masato
    MOLECULAR THERAPY, 2009, 17 : S232 - S232
  • [7] ANTI TGF-β PANCREATIC CANCER GENE THERAPY WITH INFECTIVITY ENHANCED ADENOVIRUS EXPRESSING SOLUBLE TGF-β RECEPTOR II
    Hoshino, Shigenori
    Adachi, Yasuo
    Brown, Eric
    Yamamoto, Masato
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1054 - 1055
  • [8] RNA Interference of Stat3 Using Adenovirus Vector Inhibits Pancreatic Cancer Growth In Vitro and In Vivo
    Huang, Chen
    Zhang, Ju Feng
    Qiu, Zheng Jun
    Zhang, Fang
    MOLECULAR THERAPY, 2006, 13 : S272 - S272
  • [9] Pancreatic Cancer-Selective Adenovirus Vector with Redesigned AB-loop Isolated via Adenovirus Library Screening Shows Specificity to Mesothelin Expressing Cells
    Miura, Yoshiaki
    Brown, Eric
    Davydova, Julia
    Yamamoto, Masato
    MOLECULAR THERAPY, 2011, 19 (07) : 1386 - 1387
  • [10] Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo
    Hirofumi Harima
    Seiji Kaino
    Taro Takami
    Shuhei Shinoda
    Toshihiko Matsumoto
    Koichi Fujisawa
    Naoki Yamamoto
    Takahiro Yamasaki
    Isao Sakaida
    BMC Cancer, 16
12345